logo
NIQ and FoodHealth Co. Launch Comprehensive Nutrition Scoring Integration

NIQ and FoodHealth Co. Launch Comprehensive Nutrition Scoring Integration

Business Wire2 days ago

CHICAGO--(BUSINESS WIRE)--NielsenIQ (NIQ), the leading consumer intelligence company, and FoodHealth Co. today announced a groundbreaking collaboration to integrate the FoodHealth Score, a next-generation nutrition intelligence tool, into NIQ's global data ecosystem.
This marks the first time NIQ, renowned for its expertise in customer intelligence and market research, will offer a comprehensive nutrient scoring system. The FoodHealth Score, developed by FoodHealth Co., is a data-driven metric that evaluates foods based on nutrient density and ingredient quality.
'Consumers are increasingly prioritizing health in their food choices, and the industry is taking notice,' said Marsha McGraw, Global Head of Partnerships and Verticals at NIQ. 'By integrating the FoodHealth Score, we're giving retailers and manufacturers a clear, data-backed way to evaluate product health impact and respond to evolving consumer expectations. This isn't just about data, it's about shaping a healthier food landscape.'
A Multi-Pronged Integration
Through this collaboration, the FoodHealth Score will be integrated into NIQ's licensable data tools, enabling retailers and manufacturers to evaluate how their products compare to others—on health—and to meet consumer demand for this information. This integration creates multiple areas of value:
Consumer-Facing Tools: The score will be embedded into NIQ's Product Insight offering, allowing retailers to integrate the FoodHealth Score, and its corresponding health insights, in the same way that they integrate Label Insights' library of attributes when in a retail environment, consumers can view scores for all foods & filter based on score threshold.
Food Industry Benchmarking: The score, and its corresponding health insights, will also be available for internal use by retailers and manufacturers who want to understand the competitive landscape and where white space exists to deliver on consumer demand for healthier options.
Academic and Policy Research: Institutions will be able to license the score to study food health trends by ZIP code, congressional district, or demographic segment and leverage the data for potential use in powering public health policy and nutritional equity efforts.
Turning Point for Conventional Food
'Health-conscious shoppers aren't a niche, they're the norm,' said Samantha Citro Alexander, Founder & CEO of FoodHealth Co. 'Consumers are scanning every aisle for healthier options, and they're willing to pay more when they can see the health difference. This is where the industry is headed, and our collaboration with NIQ is a game-changer for food companies looking to lead the way.'
For decades, NIQ clients—including the largest food retailers and manufacturers—have relied on its data to track market performance, optimize product strategies, and uncover consumer insights. Now, with the integration of the FoodHealth Score, they can go even deeper by connecting product data with real health impact, shaping product development, and aligning with evolving consumer priorities.
Upcoming Reports and Insights
To demonstrate the power of this integration, NIQ and FoodHealth Co. will co-release a series of reports over the coming months to illuminate regional health disparities through the lens of food availability and consumption, offering unprecedented insight for policymakers, retailers, and public health leaders.
About FoodHealth Co.
FoodHealth Co. is a nutrition intelligence company redefining how we understand food and its impact on the body. Through its clinical research-backed FoodHealth Score, the company provides data tools that help consumers make better choices, retailers curate smarter shelves, and brands design with health in mind. With real-world integrations into major grocery chains, FoodHealth Co. believes that the future of health is food. Formerly known as bitewell, the company is headquartered in San Francisco.
About NIQ
NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world's population and more than $7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.
For more information, please visit www.niq.com.
© 2025 Nielsen Consumer LLC. All Rights Reserved.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer
eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer

Yahoo

time29 minutes ago

  • Yahoo

eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer

Global eClinical Connect events kick off this week, leading up to annual ENGAGE conference in the fall, as company continues to build innovative avenues to empower life sciences leaders BOSTON, June 04, 2025--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced its participation in several June events, including the DIA 2025 Global Annual Meeting, a leading life sciences event that brings together industry professionals to drive large-scale collaboration and transformation in the sector. With the company's commitment to supporting biopharma researchers in driving tomorrow's breakthroughs, eClinical is also hosting the eClinical Connect event series, including two events in Europe, creating additional global forums for industry experts to share insights and actionable strategies to tackle today's most pressing issues in the life sciences. DIA 2025 Global Annual Meeting Following years of industry and regulatory efforts to ensure inclusive and representative trials, including Diversity Action Plans, leaders are collaborating to make tangible progress on initiatives promoting clinical trial diversity. To support these efforts, eClinical Solutions will host a panel at DIA (June 15-19 in Washington, DC) titled "Techquity in Digital Trials: Tech, Data, and Operationalizing Equity in Clinical Research," which will explore how biopharma can leverage data foundations and technological advancements - including artificial intelligence (AI) and machine learning (ML) - to improve access and representation in clinical trials. eClinical Solutions' Katrina Rice, Chief Delivery Officer of Biometrics Services, will chair the panel and be joined by industry authorities including Patrick Gee, Patient Advocate, Founder and Chief Executive Hope Dealer at iAdvocate, Inc., Nicole Ward, Senior Product Manager, Business Insights and Technology at Bristol Myers Squibb, and Del Smith, CEO and Co-founder at Acclinate. The discussion will focus on critical areas where technology and analytics can help facilitate health equity advancement, outline concrete use cases where technology and data can support equitable clinical research, and detail non-technical success factors needed to wholly support data-driven technology. The conversation will take place June 18 between 1:45 pm - 2:45 pm ET. eClinical Connect In addition to its presence at this premier industry conference, the company will host three complimentary, global eClinical Connect events this month, which feature timely and informative panel discussions: eClinical Connect in Newton, Massachusetts, USA (June 4): The first event will focus on considerations for adopting risk-based approaches, which continue to be top of mind as regulatory demands increase and clinical trials become more complex. eClinical Connect in Mainz, Germany (June 10): The first European installment will include half-day presentations, providing attendees with insight on future-ready data strategies, elluminate Clinical Data Cloud® adoption case studies presented by prominent Top 50 biopharma, and the eClinical Solutions vision and elluminate roadmap – including use cases for enabling clinical teams with robust data transformation tools. eClinical Connect in Paris, France (June 12): Later the same week in Europe, the Paris Connect's sessions and speakers will cover AI strategies, holistic approaches to risk-based quality management (RBQM), expanding clinical data platform use cases across an organization, and a CRO's experience streamlining data cleaning with a centralized data workbench. "With a massive technology reinvention upon us thanks to the growing power and priority level of AI, it was important for us to supplement distinguished industry events like DIA with additional forums for collaboration with our clients and other life sciences stakeholders to discuss the most effective clinical trial strategies and approaches," said Raj Indupuri, Co-founder and CEO at eClinical Solutions. "During this unprecedented time, we must carefully examine how to most effectively harness AI tools safely with trust to improve key industry pain points. We are proud to convene top minds in life sciences at our eClinical Connect events to not only discuss unlocking AI's potential across the clinical data lifecycle, but also dive into other pertinent topics including holistic RBQM and risk-based approaches to optimize cycle times and future-proof trials, ultimately delivering innovative therapies to patients faster." eClinical Solutions has also revealed details into this year's ENGAGE Annual Conference, which will be held October 29-30 in Philadelphia, Pennsylvania. The event will provide executives the opportunity to explore the latest advancements in AI-driven innovation, insight into risk-based strategies to optimize decision-making, and tactical ways teams can reduce cycle times and improve efficiency. To learn more about these events, including how you can register to attend, visit the eClinical Solutions website: About eClinical Solutions eClinical Solutions' industry-leading data & analytics platform, elluminate®, and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations manage trial complexity in less time and with fewer resources. Clients get accurate and timely data insights for better decision-making – enabling them to reduce cycle times, improve productivity, easily scale, and develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplaces Culture Excellence Award, 2024 Top Workplaces USA Award, and Great Place To Work® India Certification™. Learn more at and follow eClinical Solutions on LinkedIn. View source version on Contacts Olivia MannioneClinical@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Veolia partners with Jamestown, Rhode Island to provide high-quality water service
Veolia partners with Jamestown, Rhode Island to provide high-quality water service

Business Wire

time30 minutes ago

  • Business Wire

Veolia partners with Jamestown, Rhode Island to provide high-quality water service

JAMESTOWN, R.I.--(BUSINESS WIRE)--Veolia North America, the leading provider of water services and environmental solutions in the U.S. and Canada, has entered a three-year agreement to operate the water treatment plant for the Town of Jamestown, Rhode Island, providing high standards of water quality and professional operation for nearly 1,600 homes and businesses in the coastal community. Leading provider of water services and environmental solutions in the U.S. and Canada enters a three-year agreement to operate the water treatment plant for Jamestown, Rhode Island Throughout the three-year contract, Veolia will provide a team of three certified, full-time professionals to operate Jamestown's plant, alleviating a staffing shortage that has become a perennial concern throughout the water sector. Veolia will provide a full contingent of certified employees to operate and maintain the water treatment plant, working in conjunction with municipal personnel to provide environmental security for the town and its residents. Jamestown's need for a deeper operational roster became apparent over a recent period when only one licensed individual was on hand to address the needs of the facility. In addition to dedicating Rhode Island-certified personnel specifically to operate the Jamestown Water Treatment Plant, Veolia has the ability to draw from its significant regional workforce to assist in meeting the facility's ever-evolving needs. Veolia will also provide opportunities for members of Jamestown's current bargaining union to attend training for water treatment operator licensing and advanced certifications, in an effort to cultivate a stronger municipal workforce for the water treatment plant. Upon mobilization in January of 2025, the Jamestown team and Veolia's support personnel wasted no time implementing effective and noticeable improvements to the facility and to water quality. Veolia's site leadership immediately identified a below-ground pump vault used for reading meters that was not appropriately structured for employees to enter it safely. In line with Veolia's non-negotiable emphasis on operational safety, site leaders installed electronic systems to take the required readings, then built a small structure with lights, handrails and rehabilitated stairs to reduce slip hazards and fall risks. Similar improvements to the plant's operating systems have resulted in immediate support for Jamestown's water quality. John Oatley, Regional Vice President for Veolia said: 'We are excited to work with the Town of Jamestown and provide the support this community deserves for the protection of both public and environmental health. Our team throughout Rhode Island and across New England has demonstrated efficiency, dedication and operational excellence. We look forward to bringing that to Jamestown and maintaining this unique area's remarkable quality of life.' Edward Mello, Jamestown Town Administrator said: 'The delivery of high-quality, safe drinking water to our residents is a paramount function of our local government services. Jamestown, like many communities, has struggled to recruit and retain qualified staff members in all areas of the services we provide. This partnership allows us the stability needed to continue this high-value service.' Veolia has a long-established reputation for high-quality operation of water and wastewater systems across southeastern New England, including facilities in Pawtucket and Woonsocket in Rhode Island, New London in Connecticut, Westborough in Massachusetts, and more. Veolia's service to the region exemplifies its global GreenUp strategy, striving to lead the ecological transformation of the planet by accelerating water quality improvement, hazardous waste treatment and disposal, decarbonization and technological innovation. A subsidiary of Veolia Group, Veolia North America (VNA) offers a full spectrum of water, waste and energy management services, including water and wastewater treatment, commercial and hazardous waste collection and disposal, energy consulting and resource recovery. VNA helps commercial, industrial, healthcare, higher education and municipality customers throughout North America. Headquartered in Boston, Mass., Veolia North America has more than 10,000 employees working at more than 350 locations across the continent. Veolia Group aims to become the benchmark company for ecological transformation. Present on five continents with 215,000 employees, the Group designs and deploys useful, practical solutions for the management of water, waste and energy that are contributing to a radical turnaround of the current situation. Through its three complementary activities, Veolia helps to develop access to resources, to preserve available resources and to renew them. In 2024, the Veolia group provided 111 million inhabitants with drinking water and 98 million with sanitation, produced 42 million megawatt hours of energy and treated 65 million tons of waste. Veolia Environnement (Paris Euronext: VIE) achieved consolidated revenue of 44.7 billion euros in 2024.

eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer
eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer

Business Wire

timean hour ago

  • Business Wire

eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer

BOSTON--(BUSINESS WIRE)-- eClinical Solutions LLC, a global provider of digital clinical software and services, today announced its participation in several June events, including the DIA 2025 Global Annual Meeting, a leading life sciences event that brings together industry professionals to drive large-scale collaboration and transformation in the sector. With the company's commitment to supporting biopharma researchers in driving tomorrow's breakthroughs, eClinical is also hosting the eClinical Connect event series, including two events in Europe, creating additional global forums for industry experts to share insights and actionable strategies to tackle today's most pressing issues in the life sciences. DIA 2025 Global Annual Meeting Following years of industry and regulatory efforts to ensure inclusive and representative trials, including Diversity Action Plans, leaders are collaborating to make tangible progress on initiatives promoting clinical trial diversity. To support these efforts, eClinical Solutions will host a panel at DIA (June 15-19 in Washington, DC) titled " Techquity in Digital Trials: Tech, Data, and Operationalizing Equity in Clinical Research," which will explore how biopharma can leverage data foundations and technological advancements - including artificial intelligence (AI) and machine learning (ML) - to improve access and representation in clinical trials. eClinical Solutions' Katrina Rice, Chief Delivery Officer of Biometrics Services, will chair the panel and be joined by industry authorities including Patrick Gee, Patient Advocate, Founder and Chief Executive Hope Dealer at iAdvocate, Inc., Nicole Ward, Senior Product Manager, Business Insights and Technology at Bristol Myers Squibb, and Del Smith, CEO and Co-founder at Acclinate. The discussion will focus on critical areas where technology and analytics can help facilitate health equity advancement, outline concrete use cases where technology and data can support equitable clinical research, and detail non-technical success factors needed to wholly support data-driven technology. The conversation will take place June 18 between 1:45 pm - 2:45 pm ET. eClinical Connect In addition to its presence at this premier industry conference, the company will host three complimentary, global eClinical Connect events this month, which feature timely and informative panel discussions: eClinical Connect in Newton, Massachusetts, USA (June 4): The first event will focus on considerations for adopting risk-based approaches, which continue to be top of mind as regulatory demands increase and clinical trials become more complex. eClinical Connect in Mainz, Germany (June 10): The first European installment will include half-day presentations, providing attendees with insight on future-ready data strategies, elluminate Clinical Data Cloud ® adoption case studies presented by prominent Top 50 biopharma, and the eClinical Solutions vision and elluminate roadmap – including use cases for enabling clinical teams with robust data transformation tools. eClinical Connect in Paris, France (June 12): Later the same week in Europe, the Paris Connect's sessions and speakers will cover AI strategies, holistic approaches to risk-based quality management (RBQM), expanding clinical data platform use cases across an organization, and a CRO's experience streamlining data cleaning with a centralized data workbench. 'With a massive technology reinvention upon us thanks to the growing power and priority level of AI, it was important for us to supplement distinguished industry events like DIA with additional forums for collaboration with our clients and other life sciences stakeholders to discuss the most effective clinical trial strategies and approaches,' said Raj Indupuri, Co-founder and CEO at eClinical Solutions. 'During this unprecedented time, we must carefully examine how to most effectively harness AI tools safely with trust to improve key industry pain points. We are proud to convene top minds in life sciences at our eClinical Connect events to not only discuss unlocking AI's potential across the clinical data lifecycle, but also dive into other pertinent topics including holistic RBQM and risk-based approaches to optimize cycle times and future-proof trials, ultimately delivering innovative therapies to patients faster." eClinical Solutions has also revealed details into this year's ENGAGE Annual Conference, which will be held October 29-30 in Philadelphia, Pennsylvania. The event will provide executives the opportunity to explore the latest advancements in AI-driven innovation, insight into risk-based strategies to optimize decision-making, and tactical ways teams can reduce cycle times and improve efficiency. To learn more about these events, including how you can register to attend, visit the eClinical Solutions website: About eClinical Solutions eClinical Solutions' industry-leading data & analytics platform, elluminate ®, and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations manage trial complexity in less time and with fewer resources. Clients get accurate and timely data insights for better decision-making – enabling them to reduce cycle times, improve productivity, easily scale, and develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplaces Culture Excellence Award, 2024 Top Workplaces USA Award, and Great Place To Work ® India Certification™. Learn more at and follow eClinical Solutions on LinkedIn.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store